{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:22:06Z","timestamp":1759191726579,"version":"3.44.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03202-1","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:15:18Z","timestamp":1759173318000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between gout, hyperuricemia, and Parkinson\u2019s disease: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"30","author":[{"given":"Fares A.","family":"Qtaishat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muaath I.","family":"Alsufi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jehad A.","family":"Yasin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdallah","family":"Abunamoos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3067-560X","authenticated-orcid":false,"given":"Izere","family":"Salomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Qutaishat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramez M.","family":"Odat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"3202_CR1","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/J.CNP.2022.06.002","volume":"7","author":"R Chen","year":"2022","unstructured":"Chen R, Berardelli A, Bhattacharya A, et al. Clinical neurophysiology of Parkinson\u2019s disease and Parkinsonism. Clin Neurophysiol Pract. 2022;7:201\u201327. https:\/\/doi.org\/10.1016\/J.CNP.2022.06.002.","journal-title":"Clin Neurophysiol Pract"},{"issue":"3","key":"3202_CR2","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/CNS.13549","volume":"27","author":"N Zhao","year":"2021","unstructured":"Zhao N, Yang Y, Zhang L, et al. Quality of life in Parkinson\u2019s disease: a systematic review and meta-analysis of comparative studies. CNS Neurosci Ther. 2021;27(3):270\u20139. https:\/\/doi.org\/10.1111\/CNS.13549.","journal-title":"CNS Neurosci Ther"},{"issue":"4","key":"3202_CR3","doi-asserted-by":"publisher","first-page":"955","DOI":"10.3390\/ANTIOX12040955","volume":"12","author":"S Chakrabarti","year":"2023","unstructured":"Chakrabarti S, Bisaglia M. Oxidative stress and neuroinflammation in Parkinson\u2019s disease: the role of dopamine oxidation products. Antioxidants. 2023;12(4):955. https:\/\/doi.org\/10.3390\/ANTIOX12040955.","journal-title":"Antioxidants"},{"issue":"1","key":"3202_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1017\/S0317167100012981","volume":"40","author":"C Shen","year":"2013","unstructured":"Shen C, Guo Y, Luo W, Lin C, Ding M. Serum urate and the risk of Parkinson\u2019s disease: results from a meta-analysis. Can J Neurol Sci. 2013;40(1):73\u20139. https:\/\/doi.org\/10.1017\/S0317167100012981.","journal-title":"Can J Neurol Sci"},{"issue":"6","key":"3202_CR5","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1212\/WNL.0000000000002351","volume":"86","author":"X Gao","year":"2016","unstructured":"Gao X, O\u2019Reilly EJ, Schwarzschild MA, Ascherio A. Prospective study of plasma urate and risk of Parkinson disease in men and women. Neurology. 2016;86(6):520\u20136. https:\/\/doi.org\/10.1212\/WNL.0000000000002351.","journal-title":"Neurology"},{"issue":"4","key":"3202_CR6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/S11910-012-0282-7","volume":"12","author":"X Chen","year":"2012","unstructured":"Chen X, Wu G, Schwarzschild MA. Urate in Parkinson\u2019s disease: more than a biomarker? Curr Neurol Neurosci Rep. 2012;12(4):367\u201375. https:\/\/doi.org\/10.1007\/S11910-012-0282-7.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"3202_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/S12883-022-02874-0","author":"A Fazlollahi","year":"2022","unstructured":"Fazlollahi A, Zahmatyar M, Alizadeh H, et al. Association between gout and the development of Parkinson\u2019s disease: a systematic review and meta-analysis. BMC Neurol. 2022. https:\/\/doi.org\/10.1186\/S12883-022-02874-0.","journal-title":"BMC Neurol"},{"key":"3202_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/S41531-022-00433-5","author":"H Chang","year":"2022","unstructured":"Chang H, Wang B, Shi Y, Zhu R. Dose-response meta-analysis on urate, gout, and the risk for Parkinson\u2019s disease. NPJ Parkinsons Dis. 2022. https:\/\/doi.org\/10.1038\/S41531-022-00433-5.","journal-title":"NPJ Parkinsons Dis"},{"issue":"30","key":"3202_CR9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000038947","volume":"103","author":"J Zhang","year":"2024","unstructured":"Zhang J, Zeng L, Bu L, et al. Association between high uric acid and the risk of Parkinson\u2019s disease: a meta-analysis. Medicine. 2024;103(30):e38947. https:\/\/doi.org\/10.1097\/MD.0000000000038947.","journal-title":"Medicine"},{"key":"3202_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/J.JBSPIN.2022.105402","author":"MA Pou","year":"2022","unstructured":"Pou MA, Orfila F, Pagonabarraga J, Ferrer-Moret S, Corominas H, Diaz-Torne C. Risk of Parkinson\u2019s disease in a Mediterranean population: a case-control study. Joint Bone Spine. 2022. https:\/\/doi.org\/10.1016\/J.JBSPIN.2022.105402.","journal-title":"Joint Bone Spine"},{"issue":"17","key":"3202_CR11","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1212\/01.WNL.0000279518.10072.DF","volume":"69","author":"A Alonso","year":"2007","unstructured":"Alonso A, Rodr\u00edguez LAG, Logroscino G, Hern\u00e1n MA. Gout and risk of Parkinson\u2019s disease: a prospective study. Neurology. 2007;69(17):1696\u2013700. https:\/\/doi.org\/10.1212\/01.WNL.0000279518.10072.DF.","journal-title":"Neurology"},{"issue":"10","key":"3202_CR12","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/J.PARKRELDIS.2015.08.030","volume":"21","author":"P Ungprasert","year":"2015","unstructured":"Ungprasert P, Srivali N, Thongprayoon C. Gout is not associated with a lower risk of Parkinson\u2019s disease: a systematic review and meta-analysis. Parkinsonism Relat Disord. 2015;21(10):1238\u201342. https:\/\/doi.org\/10.1016\/J.PARKRELDIS.2015.08.030.","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"3202_CR13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/S12883-018-1234-X","volume":"19","author":"JA Singh","year":"2019","unstructured":"Singh JA, Cleveland JD. Gout and the risk of Parkinson\u2019s disease in older adults: a study of U.S. Medicare data. BMC Neurol. 2019;19(1):5. https:\/\/doi.org\/10.1186\/S12883-018-1234-X.","journal-title":"BMC Neurol"},{"key":"3202_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/S13643-016-0384-4","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016. https:\/\/doi.org\/10.1186\/S13643-016-0384-4.","journal-title":"Syst Rev"},{"key":"3202_CR15","unstructured":"Study Quality Assessment Tools. NHLBI, NIH. https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools. Accessed 3 April 2025."},{"issue":"19","key":"3202_CR16","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1001\/JAMA.280.19.1690","volume":"280","author":"J Zhang","year":"1998","unstructured":"Zhang J, Yu KF. What\u2019s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280(19):1690\u20131. https:\/\/doi.org\/10.1001\/JAMA.280.19.1690.","journal-title":"JAMA"},{"issue":"7109","key":"3202_CR17","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/BMJ.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334. https:\/\/doi.org\/10.1136\/BMJ.315.7109.629.","journal-title":"BMJ"},{"key":"3202_CR18","unstructured":"Operating characteristics of a rank correlation test for publication bias\u2014PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/7786990\/. Accessed 3 April 2025."},{"key":"3202_CR19","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.parkreldis.2018.03.026","volume":"52","author":"M Cortese","year":"2018","unstructured":"Cortese M, Riise T, Engeland A, Ascherio A, Bj\u00f8rnevik K. Urate and the risk of Parkinson\u2019s disease in men and women. Parkinsonism Relat Disord. 2018;52:76\u201382. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.03.026.","journal-title":"Parkinsonism Relat Disord"},{"issue":"11","key":"3202_CR20","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1002\/ART.24193","volume":"59","author":"M De Vera","year":"2008","unstructured":"De Vera M, Rahman MM, Rankin J, Kopec J, Gao X, Choi H. Gout and the risk of Parkinson\u2019s disease: a cohort study. Arthritis Rheum. 2008;59(11):1549\u201354. https:\/\/doi.org\/10.1002\/ART.24193.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"3202_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12883-020-01916-9\/TABLES\/4","volume":"20","author":"LY Hu","year":"2020","unstructured":"Hu LY, Yang AC, Lee SC, et al. Risk of Parkinson\u2019s disease following gout: a population-based retrospective cohort study in Taiwan. BMC Neurol. 2020;20(1):1\u20137. https:\/\/doi.org\/10.1186\/S12883-020-01916-9\/TABLES\/4.","journal-title":"BMC Neurol"},{"key":"3202_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/MEDICINA57121292","author":"JH Kim","year":"2021","unstructured":"Kim JH, Choi IA, Kim A, Kang G. Clinical association between gout and Parkinson\u2019s disease: a nationwide population-based cohort study in Korea. Medicina (Kaunas). 2021. https:\/\/doi.org\/10.3390\/MEDICINA57121292.","journal-title":"Medicina (Kaunas)"},{"issue":"3","key":"3202_CR23","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/J.IJGE.2013.01.006","volume":"8","author":"SW Lai","year":"2014","unstructured":"Lai SW, Lin CH, Lin CL, Liao KF. Gout and Parkinson\u2019s disease in older people: an observation in Taiwan. Int J Gerontol. 2014;8(3):166\u20137. https:\/\/doi.org\/10.1016\/J.IJGE.2013.01.006.","journal-title":"Int J Gerontol"},{"issue":"4","key":"3202_CR24","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/S10654-013-9791-1","volume":"28","author":"E Schernhammer","year":"2013","unstructured":"Schernhammer E, Qiu J, Wermuth L, Lassen CF, Friis S, Ritz B. Gout and the risk of Parkinson\u2019s disease in Denmark. Eur J Epidemiol. 2013;28(4):359\u201360. https:\/\/doi.org\/10.1007\/S10654-013-9791-1.","journal-title":"Eur J Epidemiol"},{"key":"3202_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/S12883-015-0273-9","author":"J Pakpoor","year":"2015","unstructured":"Pakpoor J, Seminog OO, Ramagopalan SV, Goldacre MJ. Clinical associations between gout and multiple sclerosis, Parkinson\u2019s disease, and motor neuron disease: record-linkage studies. BMC Neurol. 2015. https:\/\/doi.org\/10.1186\/S12883-015-0273-9.","journal-title":"BMC Neurol"},{"issue":"1","key":"3202_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-023-30379-4","volume":"13","author":"EJ Lee","year":"2023","unstructured":"Lee EJ, Kim SY, Choi HG, et al. Longitudinal follow-up study of the association with gout and Alzheimer\u2019s disease, and Parkinson\u2019s disease in Korea. Sci Rep. 2023;13(1):1\u201311. https:\/\/doi.org\/10.1038\/s41598-023-30379-4.","journal-title":"Sci Rep"},{"key":"3202_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/S41467-023-38602-6","author":"A Topiwala","year":"2023","unstructured":"Topiwala A, Mankia K, Bell S, et al. Association of gout with brain reserve and vulnerability to neurodegenerative disease. Nat Commun. 2023. https:\/\/doi.org\/10.1038\/S41467-023-38602-6.","journal-title":"Nat Commun"},{"issue":"1","key":"3202_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13195-024-01476-X\/FIGURES\/3","volume":"16","author":"T Zhang","year":"2024","unstructured":"Zhang T, An Y, Shen Z, et al. Serum urate levels and neurodegenerative outcomes: a prospective cohort study and mendelian randomization analysis of the UK Biobank. Alzheimer Res Ther. 2024;16(1):1\u201310. https:\/\/doi.org\/10.1186\/S13195-024-01476-X\/FIGURES\/3.","journal-title":"Alzheimer Res Ther"},{"issue":"5","key":"3202_CR29","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/AJE\/KWM127","volume":"166","author":"MG Weisskopf","year":"2007","unstructured":"Weisskopf MG, O\u2019Reilly E, Chen H, Schwarzschild MA, Ascherio A. Plasma urate and risk of Parkinson\u2019s disease. Am J Epidemiol. 2007;166(5):561\u20137. https:\/\/doi.org\/10.1093\/AJE\/KWM127.","journal-title":"Am J Epidemiol"},{"issue":"9","key":"3202_CR30","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1093\/AJE\/KWP033","volume":"169","author":"H Chen","year":"2009","unstructured":"Chen H, Mosley TH, Alonso A, Huang X. Plasma urate and Parkinson\u2019s disease in the Atherosclerosis risk in communities (ARIC) study. Am J Epidemiol. 2009;169(9):1064\u20139. https:\/\/doi.org\/10.1093\/AJE\/KWP033.","journal-title":"Am J Epidemiol"},{"issue":"5","key":"3202_CR31","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1093\/OXFORDJOURNALS.AJE.A008954","volume":"144","author":"JW Davis","year":"1996","unstructured":"Davis JW, Grandinetti A, Waslien CI, Ross GW, White LR, Morens DM. Observations on serum uric acid levels and the risk of idiopathic Parkinson\u2019s disease. Am J Epidemiol. 1996;144(5):480\u20134. https:\/\/doi.org\/10.1093\/OXFORDJOURNALS.AJE.A008954.","journal-title":"Am J Epidemiol"},{"issue":"5","key":"3202_CR32","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/ANA.20663","volume":"58","author":"LML De Lau","year":"2005","unstructured":"De Lau LML, Koudstaal PJ, Hofman A, Breteler MMB. Serum uric acid levels and the risk of Parkinson\u2019s disease. Ann Neurol. 2005;58(5):797\u2013800. https:\/\/doi.org\/10.1002\/ANA.20663.","journal-title":"Ann Neurol"},{"issue":"7","key":"3202_CR33","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/MDS.23070","volume":"25","author":"A Winquist","year":"2010","unstructured":"Winquist A, Steenland K, Shankar A. Higher serum uric acid associated with decreased Parkinson\u2019s disease prevalence in a large community-based survey. Mov Disord. 2010;25(7):932\u20136. https:\/\/doi.org\/10.1002\/MDS.23070.","journal-title":"Mov Disord"},{"issue":"2","key":"3202_CR34","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/S11926-010-0083-4","volume":"12","author":"A Alonso","year":"2010","unstructured":"Alonso A, Sovell KA. Gout, hyperuricemia, and Parkinson\u2019s disease: a protective effect? Curr Rheumatol Rep. 2010;12(2):149\u201355. https:\/\/doi.org\/10.1007\/S11926-010-0083-4.","journal-title":"Curr Rheumatol Rep"},{"issue":"7","key":"3202_CR35","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3390\/ANTIOX9070597","volume":"9","author":"KH Chang","year":"2020","unstructured":"Chang KH, Chen CM. The role of oxidative stress in Parkinson\u2019s disease. Antioxidants. 2020;9(7):597. https:\/\/doi.org\/10.3390\/ANTIOX9070597.","journal-title":"Antioxidants"},{"issue":"1","key":"3202_CR36","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/S13311-016-0497-4","volume":"14","author":"S Paganoni","year":"2016","unstructured":"Paganoni S, Schwarzschild MA. Urate as a marker of risk and progression of neurodegenerative disease. Neurotherapeutics. 2016;14(1):148. https:\/\/doi.org\/10.1007\/S13311-016-0497-4.","journal-title":"Neurotherapeutics"},{"key":"3202_CR37","doi-asserted-by":"publisher","DOI":"10.2174\/1874205X-V16-E2207140","author":"Z Misri","year":"2022","unstructured":"Misri Z, Pillarisetti S, Nayak P, Mahmood A, Ahmed S, Unnikrishnan B. Correlation of serum uric acid with cognition, severity, and stage of disease in patients with idiopathic Parkinson\u2019s disease and vascular Parkinsonism: a cross-sectional study. Open Neurol J. 2022. https:\/\/doi.org\/10.2174\/1874205X-V16-E2207140.","journal-title":"Open Neurol J"},{"issue":"12","key":"3202_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS21124269","volume":"21","author":"VL Halperin Kuhns","year":"2020","unstructured":"Halperin Kuhns VL, Woodward OM. Sex differences in urate handling. Int J Mol Sci. 2020;21(12):4269. https:\/\/doi.org\/10.3390\/IJMS21124269.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3202_CR39","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/S13075-021-02701-W","volume":"23","author":"Y Eun","year":"2021","unstructured":"Eun Y, Kim IY, Han K, et al. Association between female reproductive factors and gout: a nationwide population-based cohort study of 1 million postmenopausal women. Arthritis Res Ther. 2021;23(1):304. https:\/\/doi.org\/10.1186\/S13075-021-02701-W.","journal-title":"Arthritis Res Ther"},{"key":"3202_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/JCSM.13561","author":"M Kang","year":"2024","unstructured":"Kang M, Baek JY, Jo Y, et al. Higher serum uric acid as a risk factor for frailty in older adults: a nationwide population-based study. J Cachexia Sarcopenia Muscle. 2024. https:\/\/doi.org\/10.1002\/JCSM.13561.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"12","key":"3202_CR41","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1002\/ACR.22648","volume":"67","author":"BT Burke","year":"2015","unstructured":"Burke BT, K\u00f6ttgen A, Law A, et al. Physical function, hyperuricemia, and gout in older adults enrolled in the atherosclerosis risk in communities cohort study. Arthritis Care Res (Hoboken). 2015;67(12):1730. https:\/\/doi.org\/10.1002\/ACR.22648.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"3202_CR42","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1053\/J.AJKD.2010.06.004","volume":"56","author":"N Tangri","year":"2010","unstructured":"Tangri N, Weiner DE. Uric acid, CKD and cardiovascular disease: confounders, culprits and circles. Am J Kidney Dis. 2010;56(2):247. https:\/\/doi.org\/10.1053\/J.AJKD.2010.06.004.","journal-title":"Am J Kidney Dis"},{"key":"3202_CR43","doi-asserted-by":"publisher","first-page":"117954682412395","DOI":"10.1177\/11795468241239542","volume":"18","author":"F Sosa","year":"2024","unstructured":"Sosa F, Shaban M, Lopez J, et al. Impact of hyperuricemia and urate-lowering agents on cardiovascular diseases. Clin Med Insights Cardiol. 2024;18:11795468241239542. https:\/\/doi.org\/10.1177\/11795468241239542.","journal-title":"Clin Med Insights Cardiol"},{"key":"3202_CR44","doi-asserted-by":"publisher","first-page":"1164756","DOI":"10.3389\/FNEUR.2023.1164756","volume":"14","author":"N Otani","year":"2023","unstructured":"Otani N, Hoshiyama E, Ouchi M, Takekawa H, Suzuki K. Uric acid and neurological disease: a narrative review. Front Neurol. 2023;14:1164756. https:\/\/doi.org\/10.3389\/FNEUR.2023.1164756.","journal-title":"Front Neurol"},{"issue":"7","key":"3202_CR45","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.3390\/CELLS9071687","volume":"9","author":"M Pajares","year":"2020","unstructured":"Pajares M, Rojo AI, Manda G, Bosc\u00e1 L, Cuadrado A. Inflammation in Parkinson\u2019s disease: mechanisms and therapeutic implications. Cells. 2020;9(7):1687. https:\/\/doi.org\/10.3390\/CELLS9071687.","journal-title":"Cells"},{"issue":"6","key":"3202_CR46","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1002\/ANA.24281","volume":"76","author":"KC Simon","year":"2014","unstructured":"Simon KC, Eberly S, Gao X, et al. Mendelian randomization of serum urate and parkinson disease progression. Ann Neurol. 2014;76(6):862\u20138. https:\/\/doi.org\/10.1002\/ANA.24281.","journal-title":"Ann Neurol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03202-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03202-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03202-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:15:20Z","timestamp":1759173320000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-03202-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3202"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03202-1","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"9 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"904"}}